Neuro-ophthalmic emergencies for the neurologist

Neurologist

Volumn 11, Issue 4, 2005, Pages 195-233

  Purvin, Valerie ^a   Kawasaki, Aki ^b  

^a MIDWEST EYE INSTITUTE   (United States)

^b HÔPITAL OPHTALMIQUE JULES GONIN   (Switzerland)

Author keywords

Acute visual loss; Emergency; Neuro ophthalmology

Indexed keywords

ALTEPLASE; BRIMONIDINE; CORTICOSTEROID; FIBRINOLYTIC AGENT; METHYLPREDNISOLONE; OSMOTIC AGENT; PENTOXIFYLLINE; PREDNISONE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ABDUCENS NERVE PARALYSIS; ANISOCORIA; ARTERY DISSECTION; ARTIFICIAL VENTILATION; BALLOON EMBOLIZATION; BRAIN VENTRICLE PERITONEUM SHUNT; CAROTID ARTERY DISEASE; CAROTID CAVERNOUS FISTULA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EMERGENCY; EYE MOVEMENT DISORDER; GAZE PARALYSIS; HOMONYMOUS HEMIANOPIA; HUMAN; HYPERBARIC OXYGEN; INFLAMMATION; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; ISCHEMIC OPTIC NEUROPATHY; MYDRIASIS; NEUROLOGIC DISEASE; NEUROMUSCULAR JUNCTION DISORDER; NEUROOPHTHALMOLOGY; OPHTHALMOPLEGIA; OPTIC NERVE DISEASE; ORBIT DISEASE; PAPILLEDEMA; PARACENTESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUPIL DISEASE; RETINA ARTERY OCCLUSION; REVIEW; SYMPTOMATOLOGY; VISUAL DISORDER; VISUAL IMPAIRMENT;

ACUTE DISEASE; BLINDNESS; CEREBROVASCULAR DISORDERS; CRANIAL NERVE DISEASES; EMERGENCIES; EYE DISEASES; HUMANS; INTRACRANIAL HYPERTENSION; MUCORMYCOSIS; NEUROMUSCULAR JUNCTION DISEASES; WERNICKE ENCEPHALOPATHY;

EID: 22244473649     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nrl.0000159981.73413.2e     Document Type: Review

References (252)

1. Balcer LJ, Beck RW. Inflammatory optic neuropathies and neuroretinitis. In: Yanoff M, Duker J, eds. Ophthalmology. 2nd ed. New York: Harcourt Health Sciences; 2004.
2. Optic Neuritis Study Group. The clinical profile of optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1991;109:1673-1678.
3. Beck RW, Cleary PA, Anderson MM, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med. 1992;326:581-588.
4. Miller DH, MacMannus DG, Bartlett PA, et al. Detection of optic nerve lesions in optic neuritis using frequency-selection fat-saturation sequences. Neurology. 1993;35:156-158.
5. Guy J, Mao J, Bidgood WD, et al. Enhancement and demyelination of the intraorbital optic nerve: fat suppression magnetic resonance imaging. Ophthalmology. 1992;99:713-719.
6. Rizzo J, Andreoli C, Rabin J. Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2002;109:1679-1684.
7. Purvin V, Kawasaki A, Jacobson D. Optic perineuritis: clinical and radiographic features. Arch Ophthalmol: 2001;119:1299-1306.
8. Beck RW, Cleary P, Trobe JD, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med. 1993;329:1764-1769.
9. Optic Neuritis Study Group. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 2003;121:944-949.
10. Optic Neuritis Study Group. Visual function more than 10 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. Am J Ophthalmol 2004;137:77-83.
11. Balcer LJ, Galetta SL. Treatment of acute demyelinating optic neuritis. Semin Ophthalmol. 2002;17:4-10.
12. Boghen D, Glaser JS. Ischaemic optic neuropathy: the clinical profile and history. Brain. 1975;98:689-708.
13. Hayreh SS. Anterior ischemic optic neuropathy. Arch Neurol. 1981; 38:675-678.
14. Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2003;23:157-163.
15. Hayreh SS, Podhajsky P, Zimmerman B. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica 1999;213:76-96.
16. Landau K, Winterkorn J, Mailloux L, et al. 24-Hour blood pressure monitoring in patients with anterior ischemic optic neuropathy. Arch Ophthalmol. 1996;114;570-575.
17. Waybright EA, Selhorst JB, Combs J. Anterior ischemic optic neuropathy with internal artery occlusion. Am J Ophthalmol. 1982;93:42-47.
18. Biousse V, Schaison M, Touboul J, et al. Ischemic optic neuropathy associated with internal carotid artery dissection. Arch Neurol. 1998; 55:715-719.
19. Lieberman MF, Shahi A, Green WR. Embolie ischemic optic neuropathy. Am J Ophthalmol. 1978;86:206-210.
20. Muller M, Kessler C, Wessel K, et al. Low-tension glaucoma: a comparative study with retinal ischemic syndromes and anterior ischemic optic neuropathy. Ophthalmic Surg. 1993;24:835-838.
21. Fry CL, Carter JE, Kanter MC, et al. Anterior ischemic optic neuropathy is not associated with carotid artery atherosclerosis. Stroke. 1993; 24:539-542.
22. The Ischemic Optic Neuropathy Decompression Trial Study Group. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol 1996;114:1366-1374.
23. The Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression for non-arteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 1995;273:625-632.
24. Newman NJ, Scherer R, Langenberg P, et al. The fellow eye in NAION: report from the Ischemic Optic Neuropathy Decompression Trial follow-up study. Am J Ophthalmol. 2002;134:317-328.
25. Connolly S, Gordon K, Horton J. Salvage of vision after hypotension-induced ischemic optic neuropathy. Am J Ophthalmol, 1994;117:235-242.
26. Mojon D, Hedges T, Ehrenberg B, et al. Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol. 2002;120:601-605.
27. Arnold AC, Hepler RS, Lieber M, et al. Hyperbaric oxygen therapy for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1996;122:535-541.
28. Woldemussie E, Ruiz G, Wijono M, et al. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest Ophthalmol Vis Sci. 2001;42:2849-2855.
29. Fazzone HE, Kupersmith MJ, Leibmann J. Does topical brimonidine tartrate help NAION? Br J Ophthalmol. 2003;87:1193-1194.
30. Sergott RC, Cohen MS, Bosley TM, et al. Optic nerve sheath decompression may improve the progressive form of nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol. 1989;107:1743-1754.
31. Soheilian M, Koockek A, Yazdani S, et al. Transvitreal optic neurotomy for nonarteritic anterior ischemic optic neuropathy. Retina. 2003; 23:692-697.
32. Salvarini C, Cantini F, Boiard L, et al. Medical progress: polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347:261-271.
33. Weyand C, Goronzy J. Giant-cell arteritis and polymyalgia rheumatica. Ann Int Med 2003;139:505-515.
34. Weyand C, Goronzy J. Mechanisms of disease: medium- and large-vessel vasculitis. N Engl J Med. 2003;349:160-169.
35. Hayreh SS, Podhajsky P, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol. 1998;125:509-520.
36. Gonzalez-Guy MA, Garcia-Porrua C, Llorca J, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 1612 patients. Medicine. 2001;79:283-292.
37. Hayreh SS, Podhajsky P, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol. 1997; 123:285-296.
38. Foroozan R, Danesh-Meyer H, Savino PJ, et al. Thrombosis in patients with biopsy proven giant cell arteritis. Ophthalmology. 2002;109: 1267-1271.
39. Weyand C, Bartley BG. Giant cell arteritis: new concepts in pathogenesis and indications for management. Am J Ophthalmol. 1997;123:392-395.
40. Arnold AC. Ischemic optic neuropathies. Ophthalmol Clin North Am. 2001;14:83-98.
41. Galetta SL. Vasculitis. In: Miller NR, Newman NJ, eds. Walsh and Hoyt's Clinical Neuro-ophthalmology. 5th ed. Baltimore: Williams and Wilkins; 1998:3725-3886.
42. Pless M, Rizzo JF III, Lamkin JC, et al. Concordance of bilateral temporal artery biopsy in giant cell arteritis. J Neuroophthalmol. 2000;20:216-218.
43. Danesh-Meyer H, Savino PJ, Eagle RC, et al. Low diagnostic yield with second biopsies in suspected giant cell arteritis. J Neuroophthalmol. 2000;20:213-215.
44. Boyev LR, Miller NR, Green WR, et al. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol. 1999;128:211-215.
45. Hall JK, Volpe N. Galetta SL, et al. The role of unilateral temporal artery biopsy. Ophthalmology. 2003;110:543-548.
46. Bhatti MT, Tabandeh H. Giant cell arteritis: diagnosis and management. Curr Opin Ophthalmol. 2001;12:393-399.
47. Guevara RA, Newman NJ, Grossniklaus HB. Positive temporal artery biopsy 6 months after prednisone treatment. Arch Ophthalmol. 1998; 116:1252-1253.
48. Ray-Chaudhuri N, Kine DA, Tijani SO, et al. Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol. 2002;86:530-532.
49. Al-Abdulla N, Miller NR. Giant cell arteritis: an update on diagnosis and management. Comp Ophthalmol Update 2002:155-166.
50. Liu GT, Glaser JS, Schatz NJ, et al. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology. 1994;101:1779-1785.
51. Chan CC, O'Day J. Oral and intravenous steroids in giant cell arteritis. Clin Exp Ophthalmol. 2003;31:179-182.
52. Hayreh SS, Zimmerman B. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies. Ophthalmologica. 2003;217:239-259.
53. Hunder GG, Sheps SG, Allen GL, et al. Daily and altemate-day corticosteroid regimens in the treatment of giant cell arteritis: comparison in a progressive study. Ann Intern Med. 1975;82:612-618.
54. Hoffman GS, Cid MC, Helman DB, et al. for the International Network for the Study of Systemic Vasculitis (INSSXS). A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 2002;46:1309-1318.
55. Spiera RF, Kupersmith M, Paget S, et al. Vision loss in giant cell arteritis. Patients treated with alternate day corticosteroids: comment on the article by Hoffrnan et al [letter]. Arthritis Rheum. 2003;48:1159-1160.
56. Hayreh SS, Zimmerman B, Kardon RH. Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of the literature. Acta Ophthalmol Scand. 2002;80:355-367.
57. Foroozan R, Deramo VA, Buono LM, et al. The recovery of visual function in patients with biopsy-proven giant cell arteritis. Ophthalmology. 2003;110:539-542.
58. Hayreh SS, Zimmerman B. Visual deterioration in giant cell arteritis while on high doses of corticosteroid therapy. Ophthalmology 2003; 110:1204-1215.
59. Aiello P. Trautmann J, McPhee T, et al. Visual prognosis in giant cell arteritis. Ophthalmology. 1993;100:550-555.
60. Turbin R, Kupersmith MJ. Delayed visual loss in patients with giant cell arteritis [abstract]. Invest Ophthalmol Vis Sci. 1998;39:S771.
61. Slavin ML, Margolis AJ. Progressive anterior ischemic optic neuropathy due to giant cell arteritis despite high-dose intravenous corticosteroids. Arch Ophthalmol. 1988;106:1167.
62. Faarrang KL, Thyssen PE. Giant cell arteritis: loss of vision during corticosteroid therapy. J Intern Med. 1989;225:215-216.
63. Rizzo JF IH, Lessell S. Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles. Arch Ophthalmol. 1991;109:1668-1672.
64. Cornblath WT, Eggenberger ER. Progressive visual loss from giant cell arteritis despite high-dose intravenous methylprednisolone. Ophthalmology. 1997;104:854-858.
65. Kim N, Trobe JT, Flint A, et al. Late ipsilateral recurrence of ischemic optic neuropathy in giant cell arteritis. J Neuroophthalmol. 2003;23: 122-126.
66. Williams E, Hart WM, Tempelhoff R. Postoperative ischemic optic neuropathy. Anesth Analg. 1995;80:1018-1029.
67. Sadda S, Lee M, Miller NR. et al. Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthalmol. 2001;132:743-750.
68. Dinowitz M, Leen J, Hameed M, et al. Sudden painless visual loss [comments by Purvin]. Surv Ophthalmol. 2001:46:143-148.
69. Ringel SP, Brick JF. Carotid-ophthalmic artery aneurysm masquerading as optic neuritis. J Neurol Neurosurg Psychiatry. 1986;49: 460.
70. Miller NR, Savino PJ, Schneider T. Rapid growth of an intracranial aneurysm causing apparent retrobulbar optic neuritis. J Neuroophthalmol. 1995;15:212-218.
71. Kalenak JW, Kosmorsky G, Hassenbusch SJ. Compression of the intracranial optic nerve mimicking unilateral normal-pressure glaucoma. J Clin Neuroophthalmol. 1992;12:230-235.
72. Purvin V, Kawasaki A, Zeldes S. Dolichoectatic arterial compression of the anterior visual pathways: neuro-ophthalmic features and clinical course. J Neurol Neurosurg Psychiatry. 2004;75:27-32.
73. Brougham M, Heusner AP. Adams RD. Acute degenerative changes in adenomas of the pituitary body-with special reference to pituitary apoplexy. J Neurosurg. 1950;7:421-439.
74. Onesti ST, Wisniewski T, Post KD. Clinical versus subclinical pituitary apoplexy: presentation, surgical management and outcome in 21 patients. Neurosurgery. 1990;26:980-986.
75. Bills DC, Meyer FB, Laws ER. A retrospective analysis of pituitary apoplexy. Neurosurgery. 1993;33:602-609.
76. Cardoso ER, Peterson EW. Pituitary apoplexy: a review. Neurosurgery. 1984;14:363-323.
77. Bonicki W, Kasperlik-Zaluska A, Koszcwski W, et al. Pituitary apoplexy: endocrine, surgical and oncological emergency: incidence, clinical course and treatment with reference to 799 cases of pituitary adenoma. Acta Neurochir. 1993;120:118-122.
78. Shin RK, Cucchiara BL, Liebeskind DS, et al. Pituitary apoplexy causing optic neuropathy and Horner syndrome without ophthalmoplegia. J Neuroophthalmol. 2003;23:208-210.
79. Milazzo S, Toussaint P, Proust F, et al. Ophthalmologic aspects of pituitary apoplexy. Eur J Ophthalmol. 1996;6:69-73.
80. Biousse V, Newman NJ, Oyesiku NM. Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry. 2001;71:542-545.
81. Liu GT. Pituitary adenomas. Curr Treat Opt Neurol. 2002;4:261-269.
82. Brown GC, Magargal LE. Central retinal artery obstruction and visual acuity. Ophthalmology. 1982;89:14-19.
83. Merchut MP, Gupta SR, Naheedy MH. The relation of retinal artery occlusion and carotid artery stenosis. Stroke. 1988;19:1239-1242.
84. Sharma S, Pater JL, Lam M, et al. Can different kinds of retinal emboli be differentiated from one another? Can J Ophthalmol. 1998;33:144-148.
85. Atebara NH, Brown GC, Cater J. Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion. Ophthalmology. 1995;102:2029.
86. Fraser S, Siriwardena D. Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev. 2002;1: CD001989.
87. Incandela L, Cesarone R, Belcara G, et al. Treatment of vascular retinal disease with pentoxifylline: a controlled randomized trial. Angiology. 2002;53:531-534.
88. Beiran I, Goldenberg I, Adir Y, et al. Early hyperbaric oxygen therapy for retinal artery occlusion. Eur J Ophthalmol. 2001;11:345-350.
89. Kattah JC, Wang DZ, Reddy C. Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion. Arch Ophthalmol. 2002;120:1234-1236.
90. Rumelt S, Dorenboim Y, Rehany U. Aggressive systemic treatment may reverse central retinal artery occlusion. Am J Ophthalmol. 1999; 128:733-738.
91. Richard G, Lerche RC, Knospe V, et al. Treatment of retinal artery occlusion with local fibrinolysis using recombinant tissue plasminogen activator. Ophthalmology. 1999;106:768-773.
92. Pedolocchia R, Puglioli M, Ragone MR, et al. Superselective intra-arterial fibrinolysis in central retinal artery occlusion. AJNR Am J Neuroradiol. 1999;20:565-567.
93. Pacques M, Vallee JN, Hebreteau D. Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion. Br J Ophthalmol. 2000;84:1387-91.
94. Schmidt DP, Schulte-Monting J, Schumacher M. Prognosis of central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment. AJNR Am J Neuroradiol. 2002;23:1301-1307.
95. Beatty S, AuEong AK. Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of published data. Br J Ophthalmol. 2000;84:914-916.
96. Hoyt WF. Transient bilateral blurring of vision. Arch Ophthalmol. 1963;70:746-751.
97. Tanne D, Goldbourt U, Zion M, et al. Frequency and prognosis of stroke/TIA among 4808 survivors of acute myocardial infarction. Stroke. 1993;24:1490-1495.
98. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494-500.
99. Delanty N, Vaughan C. Frucht S, et al. Erythroprotein-associated hypertensive posterior encephalopathy. Neurology. 1997;49:686-689.
100. Ito Y, Arahata Y, Goto Y, et al. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol. 1998;19:415-417.
101. Kupferschmidt H, Boni A, Schnorf H, et al. Transient cortical blindness and bioccipital brain lesions in two patients with acute intermittent porphyria. Ann Intern Med. 1995;123:598-600.
102. Borgna-Pignatti C, Battisi L, Marradi P, et al. Transient neurologic disturbances in a child treated with moderate-dose methotrexate. Br J Haematol. 1992;81:448.
103. Vaughn DJ, Jarvik JG, Hackney D. et al. High-dose cytarabine neurotoxicity: MR findings during the acute phase. AJNR Am J Neuroradiol. 1991;14:1014-1016.
104. Shin RK, Stern JW, Hanss AJ, et al. Reversible posterior leukoencephalopathy during treatment of acute lymphoblastic leukemia [case reports]. Neurology. 2001;56:388-391.
105. Nakazato T, Nagasaki A, Nakamura K, et al. Reversible posterior leukoencephalopathy syndrome associated with tacrolimus therapy. Intern Med. 2003;42:624-625.
106. Celik O, Hascalik S. Reversible posterior leukoencephalopathy in eclampsia. Int J Gynecol Obstet. 2003;82:67-69.
107. Sundgren PC, Edvardsson B, Hollas S. Serial investigation of perfusion disturbances and vasogenic oedema in hypertensive encephalopathy by diffusion and perfusion weighted imaging. Neuroradiology. 2002;44: 299-304.
108. Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging and SPECT imaging in 14 cases. AJR Am J Roentgenol. 1992;159:379-383.
109. Ay H, Buonanno FS, Schaefer PW, et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology. 1998;51:1369-1376.
110. Dillon WP, Rowley H. The reversible posterior cerebral edema syndrome. AJNR Am J Neuroradiol. 1998;19:591.
111. Purvin VA, Trobe JD, Kosmorsky G. Neuro-ophthalmic features of cerebral venous obstruction. Arch Neurol. 1995;52:880-885.
112. Sadun AA, Curried JN, Lessell S, Transient visual obscurations with elevated optic discs. Ann Neurol. 1984;16:489-494.
113. Corbett JJ, Mehta MP. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology. 1983;33: 1386-1388.
114. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59:1492-1495.
115. Digre KB, Corbett JJ. Idiopathic intracranial hypertension (pseudotumor cerebri): a reappraisal. Neurologist. 2001;7:2-67.
116. Bandyopadhyay S, Jacobson DM. Clinical features of late-onset pseudotumor cerebri fulfilling the modified Dandy criteria. J Neuroophthalmol. 2002;22:9-11.
117. Scott IU, Siatkowski RM, Eneyni M, et al. Idiopathic intracranial hypertension in children and adolescents. Am J Ophthalmol. 1997;124: 253-255.
118. Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology 1999;53:1537-1542.
119. Biousse V. Bousser M-G. Cerebral venous thrombosis. Neurologist 1999;5:326-349.
120. Corbett JJ, Savino PJ, Thompson S, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol. 1982;39: 461-474.
121. Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain. 1991;114:155-180.
122. Wall M, White WN. Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest Ophthatmol Vis Sci. 1998;39:134-142.
123. Lessell S, Rosman NP, Permanent visual impairment in childhood pseudotumor cerebri. Arch Neurol. 1986;43:801-804.
124. Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology. 1997;49:734-739.
125. Rosenberg ML, Corbett JJ, Smith C, et al. Cerebrospinal diversion procedures in pseudotumor cerebri. Neurology. 1993;43:1071-1072.
126. Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology. 1996;46:1524-1530.
127. Theodosopoulous PV, Abosch A, McDermott MW. Intraoperative fiber-optic endoscopy for ventricular catheter insertion. Can J Neurol Sci. 2001;28:56-60.
128. Tulipan N, Lavin PJ, Copeland M. Stereotactic ventriculoperitoneal shunt for idiopathic intracranial hypertension. Neurosurgery. 1998;43: 175-177.
129. Banta JT, Farris BK. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology. 2000;107:1907-1912.
130. Plotnik JL, Kosmorsky GS. Operative complications of optic nerve sheath decompression. Ophthalmology. 1993;100:683-690.
131. Rizzo JF III, Lessell S. Choroidal infarction after optic nerve sheath fenestration. Ophthalmology. 1994;101:1622-1626.
132. Spoor TC, McHenry JG. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol. 1993;111: 632-635.
133. Horton J, Seiff S, Pitts L, et al. Decompression of the optic nerve sheath for vision threatening papilledema caused by dural sinus occlusion. Neurosurgery. 1992;31:203-212.
134. Johnston ER, Corbett EL, Foster O, et al. Raised intracranial pressure and visual complications in AIDS patients with cryptococcal meningitis. J Infect. 1992;24:185-189.
135. Garrity JA, Herman DC, Imes R, et al. Optic nerve sheath decompression for visual loss in patients with acquired immunodeficiency syndrome and cryptococcal meningitis with papilledema. Am J Ophthalmol. 1993;116:472-478.
136. Kelman SE, Sergott RC, Cioffi GA, et al. Modified optic nerve decompression in patients with functioning lumboperitoneal shunts and progressive visual loss. Ophthalmology 1991;98:1449E1453.
137. Mauriello JA Jr, Shaderwfsky P, Gizzi M, et al. Management of visual loss after optic nerve sheath decompression in patients with pseudotumor cerebri syndrome. Ophthalmology 1995;102:441-445.
138. Kidron D, Pomeranz S. Malignant pseudotumor cerebri: report of two cases. J Neurosurg. 1989;71:443-445.
139. Hayreh SS, Servais GE, Virdi PS. Fundus lesions in malignant hypertension. V. Hypertensive optic neuropathy. Ophthalmology. 1986;93:74-87.
140. Cove DH, Seddon M, Fletcher RF, et al. Blindness after treatment for malignant hypertension. BMJ 1979:245-246.
141. Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest. 2000;188:214-227.
142. Baumbach GL, Cancilla PA, Martin-Amat G, et al. Methyl alcohol poisoning: IV. Alternations of the morphological findings of the retina and optic nerve. Arch Ophthalmol. 1977;95:1859-1865.
143. Hayreh MS, Hayreh SS, Baumbach GL, et al. Methyl alcohol poisoning: III. Ocular toxicity. Arch Ophthalmol. 1977;95:1851-1858.
144. Josephs HW. Hypervitaminosis A and carotinemia. Am J Dis Child. 1954;87:731-736.
145. Katz B. Disc edema subsequent to renal transplantation. Surv Ophthalmol. 1997;41:315-320.
146. Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol. 1995;165:627-631.
147. Mantyjarvi M, Tuppurainen K, Ikaheimo K. Ocular side effects of amiodarone. Surv Ophthalmol. 1998;42:360-366.
148. Macaluso DC, Shults WT, Fraunfelder FT. Features of amiodarone-induced optic neuropathy. Am J Ophthalmol. 1999;127:610-612.
149. Nagra PK, Foroozan R, Savino PJ, et al. Amiodarone induced optic neuropathy. Br J Ophthalmol. 2003;87:420-422.
150. Purvin V, Kawasaki A, Borruat F-X. Amiodarone optic neuropathy. Presented during a poster session of a meeting of the North American Neuroophthalmology Society; 2004; Orlando, Florida.
151. Lubow M, Makley TA Jr. Pseudopapilledema of juvenile diabetes mellitus. Arch Ophthalmol. 1971;85:417-422.
152. Appen RE, Chandra SR, Klein R. et al. Diabetic papillopathy. Am J Ophthalmol. 1980;90:203-209.
153. Barr CC, Glaser JS, Blankenship G. Acute disc swelling in juvenile diabetes. Clinical profile and natural history of 12 cases. Arch Ophthalmol. 1980;98:2185-2192.
154. Pavan PR, Aiello LM, Wafai MZ, et al. Optic disc edema in juvenile-onset diabetes. Arch Ophthalmol. 1980;98:2193-2195.
155. Regillo CD, Brown GC, Savino PJ, et al. Diabetic papillopathy. Patient characteristics and fundus findings. Arch Ophthalmol. 1995;113:889-895.
156. Almog Y, Goldstein M. Visual outcome in eyes with asymptomatic optic disc edema. J Neuroophthalmol. 2003;23:204-207.
157. Sugita Y, Kjima S, Teshima T, et al. Marked episodic elevation of cerebrospinal fluid pressure during nocturnal sleep in patients with sleep apnea hypersomnia syndrome. Electroencephalogr Clin Neurophysiol. 1985;60:214-219.
158. Lee AG, Golnik K, Kardon R, et al. Sleep apnea and intracranial hypertension in men. Ophthalmology. 2002;109:482-485.
159. Marcus DM, Lynn J, Miller JJ, et al. Sleep disorders: a risk factor for pseudotumor cerebri? J Neuroophthalmol. 2001;21:121-123.
160. Purvin VA, Kawasaki A, Yee KD. Papilledema and obstructive sleep apnea syndrome. Arch Ophthalmol. 2000;118:1626-1630.
161. Yuen SJ, Rubin PA. Idiopathic orbital inflammation; distribution, clinical features, and treatment outcome. Arch Ophthalmol. 2003;121: 491-499.
162. Lacey B, Chang W, Rootman J. Nonthyroid causes of extraocular muscle disease. Surv Ophthalmol. 1999;44:187-213.
163. Serop S, Vianna RN, Claeys M, et al. Orbital myositis secondary to systemic lupus erythematosus. Acta Ophthalmol. 1994;72:520-523.
164. Comblath WT, Elner V, Rolfe M. Extraocular muscle involvement in sarcoidosis. Ophthalmology. 1993;100:501-505.
165. Durno CA, Erlich R, Taylor R, et al. Keeping an eye on Crohn's disease: orbital myositis as the presenting symptom. Can J Gastroenterol 1997:497-500.
166. Squires RH Jr, Zwiener RJ, Kennedy RH. Orbital myositis and Crohn's disease. J Pediatr Gastroenterol Nutr. 1992;15:448-451.
167. Carvounis PE, Mehta AP, Geist CE. Orbital myositis associated with Borrelia burgdorferi (Lyme disease) infection. Ophthalmology. 2004; 111:1023-1028.
168. Pinchoff BS, Spahlinger DA, Bergstrom TJ, et al. Extraocular muscle involvement in Wegener's granulomatosis. J Clin Neuroophthalmol. 1983;3:163-168.
169. Harris GJ, Murphy ML, Schmidt EW, et al. Orbital myositis as a paraneoplastic syndrome. Arch Ophthalmol. 1994;112:380-386.
170. Mombaerts I, Koorneef L. Current status in the treatment of orbital myositis. Ophthalmology. 1997;104:402-408.
171. Artis WM, Fountain JA, Delcher HK, et al. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferring and iron availability. Diabetes. 1982;31:1109-1114.
172. Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10:31-47.
173. Talmi YP, Goldschmied-Reouven A, Bakon M, et al. Rhino-orbital and rhino-orbito-cerebral mucormycosis. Otolaryngol Head Neck Surg. 2002;127:22-31.
174. Yohai RA, Bullock JD, Aziz AA, et al. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol. 1994;39:3-22.
175. Blitzer A, Lawson W, Meyers BR, et al. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope. 1980;90:635-648.
176. Southwick FS, Richardson EP Jr, Swartz MN. Septic thrombosis of the dural venous sinuses. Medicine. 1986;65:82-106.
177. Tveteras K, Kristensen S, Dommerby H. Septic cavernous and lateral sinus thrombosis: modern diagnostic and therapeutic principles. J Laryngol Otol. 1988;102:877-882.
178. Bhatia K, Jones NS. Septic cavernous sinus thrombosis secondary to sinusitis: are anticoagulants indicated? A review of the literature. J Laryngol Otol. 2002;116:667-676.
179. Ebright JR, Pace MT, Niazi AF. Septic thrombosis of the cavernous sinuses. Arch Intern Med. 2001;161:2671-266.
180. deKeizer R. Carotid-cavernous and orbital arteriovenous fistulas: ocular features, diagnostic and hemodynamic considerations in relation to visual impairment and morbidity. Orbit. 2003;22:121-142.
181. Jacobson D, McCanna TD, Layde PM. Risk factors for ischemic ocular motor nerve palsies. Arch Ophthalmol. 1994;112:961-966.
182. Jacobson D, Brogte S. Early progression of ophthalmoplegia in patients with ischemic oculomotor palsies. Arch Ophthalmol. 1995;113:1535-1537.
183. Kissel JT, Burde RM, Klingele TG, et al. Pupil-sparing oculomotor palsies with internal carotid-posterior communicating artery aneurysms. Ann Neurol. 1983;13:149-154.
184. Demierre B, Safran AB. Paralysies du III nerf cranien ischemique et aneurysmale: la signification de la douleur le diagnostic differential. J Fr Ophtalmol. 1981;4:133-141.
185. Trobe JD. Isolated pupil-sparing third nerve palsy. Ophthalmology. 1985;92:58-61.
186. Jacobson DM. Pupil involvement in patients with diabetes-associated oculomotor nerve palsy. Arch Ophthalmol. 1998;116:723-727.
187. Trobe JD. Third nerve palsy and the pupil: footnotes to the rule. Arch Ophthalmol. 1988;106:601-602.
188. Lee AG, Hayman LA, Brazis PW. The evaluation of isolated third nerve palsy revisited: an update on the evolving role of magnetic resonance, computed tomography and catheter angiography. Surv Ophthalmol. 2002;47:137-157.
189. Sanders S, Kawasaki A, Purvin VA. Patterns of extraocular muscle weakness in vasculopathic pupil-sparing, incomplete third nerve palsy. J Neuroophthalmol. 2001;21:256-259.
190. Trobe JD. Managing oculomotor nerve palsy. Arch Ophthalmol. 1998; 116:798.
191. Jacobson DM, Trobe JD. The emerging role of magnetic resonance angiography in the management of patients with third cranial nerve palsy. Am J Ophthalmol. 1999;128:94-96.
192. Peters GB III, Bakri SJ, Krohel GB. Cause and prognosis of non-traumatic sixth nerve palsies in young adults. Ophthalmology. 2002; 109:1925-1928.
193. Kline LB, Hoyt WF. The Tolosa-Hunt syndrome. J Neurol Neurosurg Psychiatry 2001;71.
194. Nguyen T-N, Polomeno R, Farmer J-P, et al. Ophthalmic complications of slit-ventricle syndrome in children. Ophthalmology. 2002;109:520-525.
195. Corbett JJ. Neuro-ophthalmologic complications of hydrocephalus and shunting procedures. Semin Neurol. 1986;6:111-123.
196. Chou SY, Digre KB. Neuro-ophthalmic complications of raised intracranial pressure, hydrocephalus, and shunt malfunction [review]. Neurosurg Clin North Am. 1999;10:587-608.
197. Katz DM, Trobe JD, Muraszko KM, et al. Shunt failure without ventriculomegaly proclaimed by ophthalmic findings. J Neurosurg. 1994;81:721-725.
198. Caplan LR. "Top of the basilar" syndrome. Stroke. 1980;30:72-79.
199. Mehler MF. The neuro-ophthalmic spectrum of the rostral basilar artery syndrome. Arch Neurol. 1988;45:966-971.
200. Mehler MF. The rostral basilar artery syndrome: diagnosis, etiology and prognosis. Neurology. 1989;39:9-16.
201. Antunez E, Estruch R, Cardenal C, et al. Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy. AJR Am J Roentgenol. 1998;171:1131-1137.
202. Weidauer S, Nichtweiss M, Lanfermann H, et al. Wernicke encephalopathy: MR findings and clinical presentation. Eur Radiol. 2003;13: 1001-1009.
203. Doherty MJ, Watson NF, Uchino K, et al. Diffusion abnormalities in patients with Wernicke encephalopathy. Neurology. 2002;58:655-657.
204. Barton JJS, Fouladvand M. Ocular aspects of myasthenia gravis. Semin Neurol. 2000;1:7-20.
205. Crane T, Yee R, Baloh R, et al. Analysis of characteristic eye movement abnormalities in internuclear ophthalmoplegia. Arch Ophthalmol. 1983;101:206E210.
206. Odel JG, Winterkorn JM, Behrens MM. The sleep test for myasthenia gravis: a safe alternative to Tensilon. J Clin Neuroophthalmol. 1991; 11:288-292.
207. Kubis KC, Danesh-Meyer HV, Savino PJ, et al. The ice test versus the rest test in myasthenia gravis. Ophthalmology. 2000;107:1995-1998.
208. Golnik KC, Pena R, Lee AG, et al. An ice test for the diagnosis of myasthenia. Ophthalmology. 1999;106:1282-1286.
209. Keesey JC. Clinical evaluation and management of myasthenia gravis. Muscle Nerve. 2004;29:484-505.
210. Van Dyk HJ, Florence L. The Tensilon test. Ophthalmology. 1980;87: 210-212.
211. Hoch W, McConville J, Helms S, et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med. 2001;7:365-368.
212. Valls-Canals J, Povidone M, Monterey J, et al. Stimulated single-fiber EMG of the frontalis and orbicularis oculi muscles in ocular myasthenia gravis. Muscle Nerve. 2003;28:501E503.
213. CAA JG. Clostridium botulinum and the ophthalmologist: a review of botulism, including biological warfare ramifications of botulinum toxin. Surv Ophthalmol. 2001;46:25-34.
214. Lam BL, Thompson HS, Corbett JJ. The prevalence of simple anisocoria. Am J Ophthalmol. 1987;104:69-73.
215. Loewenfeld IE. Lesions in the ciliary ganglion and short ciliary nerves: the tonic pupil ("Adie's" syndrome). In: The Pupil. Anatomy, Physiology and Clinical Applications. Vol. 1. Detroit: Wayne State University Press; 1993:1080:-1130.
216. Thompson HS. Segmental palsy of the iris sphincter in Adie's syndrome. Arch Ophthalmol. 1978;96:1615-1620.
217. Bourgon P, Pilley SFJ, Thompson. Cholinergic supersensitivity of the iris sphincter in Adie's tonic pupil. Am J Ophthalmol 1978;85:373-377.
218. Jacobson DM. Pupillary responses to dilute pilocarpine in preganglionic third nerve disorders. Neurology. 1990;40:804-808.
219. Thompson HS, Newsome DA, Loewenfeld IE. The fixed dilated pupil. Sudden iridoplegia or mydriatic drops? A simple diagnostic test. Arch Ophthalmol. 1971;86:21-27.
220. Jacobson DM. Benign episodic unilateral mydriasis. Ophthalmology. 1995;102:1623-1627.
221. Woods D, O'Connor PS, Fleming R. Episodic unilateral mydriasis and migraine. Am J Ophthalmol. 1984;98:229-234.
222. Purvin VA. Adie's tonic pupil secondary to migraine. J Neuroophthalmol. 1995;15:43-44.
223. Thompson HS, Zackon DH, Czamecki JSC. Tadpole shaped pupils caused by segmental spasm of the iris dilator muscle. Am J Ophthalmol. 1983;96:467-477.
224. Keane JR. Oculosympathetic paresis. Analysis of 100 hospitalized patients. Arch Neurol. 1979;36:13-16.
225. Giles CL, Henderson JW. Homer's syndrome: an analysis of 216 cases. Am J Ophthalmol. 1958;46:289-296.
226. Mokri B. Traumatic and spontaneous extracranial internal carotid artery dissection: early diagnosis and management J Neurol. 1990;237:356-361.
227. Biousse V, Woimant F, Amarenso P, et al. Pain as the only manifestation of extracranial internal carotid artery dissection. Cephalalgia. 1992;12:313-317.
228. Silbert PL, Mokri B, Schievink WI. Headache and neck pain in spontaneous internal carotid and vertebral artery dissection. Neurology. 1995;45:1517-1522.
229. Biousse V, D'Anglejean-Chatillon J, Massion H, et al. Head pain in non traumatic artery dissection: a series of 65 patients. Cephalalgia. 1994;14:33-36.
230. Guillon B, Biousse V, Massion H, et al. Isolated long lasting facial pain due to internal carotid artery dissection. Cephalalgia. 1998;18:222-224.
231. Biousse V, Touboul PJ, et al. Ophthalmologic manifestations of internal carotid artery dissection. Am J Ophthalmol 1998;126:565-577.
232. Kline LB, Vitek JJ, Raymon BC. Painful Horner's syndrome due to spontaneous carotid artery dissection. Ophthalmology. 1987;94:226-230.
233. Mokri B, Sundt TM, Houser OW. Spontaneous internal carotid dissection, hemicrania, and Homer's syndrome. Arch Neurol. 1979;36:677-680.
234. Bilbao R, Amoros S, Murubeu. Homer syndrome as an isolated manifestation of an intrapetrous internal carotid artery dissection. Am J Ophthalmol 1997;123:562-564.
235. Newman NJ, Kline LB, et al. Ocular stroke and carotid artery dissection. Neurology. 1989;19:126-138.
236. Rao TH, Schneider LB, Patel M, et al. Central retinal artery occlusion from carotid dissection diagnosed by cervical computed tomography. Stroke. 1994;25:1271-1272.
237. McDonough RL, Forteza AM, Flynn HW Jr. Internal carotid artery dissection causing a branch retinal artery occlusion in a young adult. Am J Ophthalmol. 1998;125:706-708.
238. Godfrey DG, Biousse V, Newman NJ. Delayed branch retinal artery occlusion following presumed blunt common carotid dissection. Arch Ophthalmol. 1998;116:1120-1121.
239. Ramadan NM, Tietjen GE, Levine SR, et al. Scintillating scotoma associated with internal carotid artery dissection: report of 3 cases. Neurology. 1991;41:1984-1987.
240. Rivkin MJ, Hedges TR, Logigian EL. Carotid dissection presenting as ischemic optic neuropathy. Neurology. 1990;40:1469.
241. Duker JS, Belmont JB. Ocular ischemic syndrome secondary to carotid artery dissection. Am J Ophthalmol. 1988;106:750-752.
242. Biousse V, D'Anglejan-Chatillon J, et al. Time course of symptoms in extracranial carotid artery dissections: a series of 80 patients. Stroke. 1995;26:235-239.
243. Mokri B, Silbert PL, et al. Cranial nerve palsy in spontaneous dissection of the extracranial carotid artery. Neurology. 1996;46:356-359.
244. Schievink W, Mokri B, et al. Ocular motor nerve palsies in spontaneous dissections of the cervical internal carotid artery. Neurology 1993;43: 1938-1941.
245. Vargas ME, Desrouleaux JR, Kupersmith MJ. Ophthalmoplegia as a presenting manifestation of internal carotid artery dissection. J Clin. Neuroophthalmol. 1992;12:268-271.
246. Galetta SL, Leahey A, Nichols CW, et al. Orbital ischemia, ophthalmoparesis, and carotid dissection. J Clin Neuroophthalmol. 1991;11: 284-287.
247. Bassi P, Lattuada P, et al. Cervical cerebral artery dissection: a multicenter prospective study-preliminary report. Neurol Sci. 2003; 24:S4-S7.
248. Pelkonen O, Tikkakoski T, et al. Extracranial internal carotid and vertebral artery dissections: angiographic spectrum, course and prognosis. Neuroradiology. 2003;45:71-77.
249. Kremer C, Mosso M, Georgiasis D, et al. Carotid dissection with permanent and transient occlusion in severe stenosis: long-term outcome. Neurology: 2003;60:271-275.
250. Rothrock JF, Lim V, et al. Serial magnetic resonance imaging in the management of carotid dissection. Neurology. 1989;39:686-692.
251. Zuccoli G, Guidetti D, et al. Carotid and vertebral artery dissection: magnetic resonance findings in 15 cases. Radiology. 2002;104:466-471.
252. Brown J, Danielson R, Donahue SP. Horner's-syndrome in subadventitial carotid artery dissection and the role of magnetic resonance angiography. Am J Ophthalmol. 1995;6:811-813.